| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +80.00% | -0.60% | +3.10% | -3.71% | -4.58% | — |
| 14d | 5 | +100.00% | -1.50% | +4.03% | -5.53% | -4.40% | — |
| 30d | 5 | +100.00% | -2.22% | +8.23% | -10.46% | -9.94% | — |
| 60d | 5 | +100.00% | -13.68% | +8.20% | -21.88% | -23.59% | — |
| 90d | 5(5 pending) | — | — | — | — | — | — |
| 180d | 5(5 pending) | — | — | — | — | — | — |
| 1y | 5(5 pending) | — | — | — | — | — | — |
| 2y | 5(5 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,389 | $114.29 | $387.3K | 47,179.438 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Business Officer | 5,000 | — | — | 90,000 | Jun 25, 2026 | Jun 25, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,500 | $119.00 | $297.5K | 50,195.438 | Jun 25, 2026 | Jun 25, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 5,000 | $21.05 | $105.3K | 55,195.438 | Jun 25, 2026 | Jun 25, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,500 | $109.00 | $272.5K | 52,695.438 | Jun 25, 2026 | Jun 25, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,500 | $99.00 | $247.5K | 50,195.438 | Jun 22, 2026 | Jun 22, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Business Officer | 2,500 | — | — | 95,000 | Jun 22, 2026 | Jun 22, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 2,500 | $21.05 | $52.6K | 52,695.438 | Jun 22, 2026 | Jun 22, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,347 | $90.00 | $121.2K | 50,195.438 | Apr 14, 2026 | Apr 16, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,000 | $87.35 | $174.7K | 51,542.438 | Apr 10, 2026 | Apr 10, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,670 | $87.11 | $232.6K | 56,042.438 | Apr 9, 2026 | Apr 10, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 2,500 | $21.05 | $52.6K | 61,806.438 | Apr 9, 2026 | Apr 10, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,094 | $86.62 | $268.0K | 58,712.438 | Apr 9, 2026 | Apr 10, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Business Officer | 2,500 | — | — | 97,500 | Apr 9, 2026 | Apr 10, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,500 | $89.00 | $222.5K | 53,542.438 | Apr 9, 2026 | Apr 10, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,450 | — | — | 18,450 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,225 | — | — | 59,306.438 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,081.438 | Apr 8, 2025 | Apr 9, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Apr 8, 2025 | Apr 9, 2025 ↗ | View → |